3989 E 170 N
Rigby, ID 83442
Phone 208-344-4476

Our Focus

The Idaho Chapter of the National Bleeding Disorders Foundation provides education, support, awareness, and advocacy for our bleeding disorder community. We are the leading resource for those affected by bleeding disorders in the state of Idaho. You can count on us to ensure your voice is heard. It’s with your help that we can make a difference. Learn more and get involved.

News Articles

CSL Behring, the biopharmaceutical company behind the hemophilia B gene therapy HEMGENIX ® (etranacogene dezaparvovec-drlb), provided an update to the bleeding disorders community regarding the availability of the treatment. In a letter to the hemophilia B community, the company stated that they have “reestablished limited supply in April 2026,” and that they remain committed to actively managing the existing supply.

In a letter sent to healthcare providers, Ferring Pharmaceuticals announced that STIMATE® (desmopressin acetate) nasal spray is expected to be available in the United States beginning October 2026.

Federal:

Medicaid Work Reporting Requirements

Envisioning a united community that will make a positive difference in the lives of individuals affected by a bleeding disorder.

Education
Advocation
Inclusions
Development

Resource Links

3989 E 170 N
Rigby, ID 83442
Phone 208-344-4476

© National Bleeding Disorders Foundation 2026

Crafted by Firespring